Iodosorb and Iodoflex
Smith & Nephew Inc (Largo, Fla)recently announced that US marketingrights for Iodosorb and Iodoflex brandswill transfer from HealthPoint to Smith& Nephew Wound Management. Withthe exception of the United States,Smith & Nephew currently owns andmarkets Iodosorb and Iodoflexthroughout the world. For the past 10years, HealthPoint has had exclusivemarketing rights in the United States.Therefore, with this transfer, Smith &Nephew will consolidate exclusiverights to market these brands worldwide.The products are indicated foruse in cleaning wet ulcers and woundssuch as venous stasis ulcers, pressuresores, and infected wounds. Iodosorbassists in wound area protection and inreducing the microbial load in thewound environment. Its unique technologyalso accounts for its capacity todeslough and absorb exudate from wetwounds and ulcers. Package sizes forboth products will remain the same,with changes only to the package appearanceto reflect Smith & Nephewcorporate branding and the new productcodes. For more information, visitwww.smith-nephew.com, or call 800-876-1261.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025